Attached files

file filename
EX-32.2 - Luckwel Pharmaceuticals Inc.ex32-2.htm
EX-31.2 - Luckwel Pharmaceuticals Inc.ex31-2.htm
EX-31.1 - Luckwel Pharmaceuticals Inc.ex31-1.htm
EX-21.1 - Luckwel Pharmaceuticals Inc.ex21-1.htm
EX-10.15 - Luckwel Pharmaceuticals Inc.ex10-15.htm
10-K - FORM 10-K - Luckwel Pharmaceuticals Inc.form10-k.htm

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Luckwel Pharmaceuticals Inc. (the “Company”) on Form 10-K for the year ended March 31, 2018 filed with the Securities and Exchange Commission (the “Report”), I, Kingrich Lee, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

   

2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

Dated: July 13, 2018 By: /s/ Kingrich Lee
  Name: Kingrich Lee
  Title: Chief Executive Officer